Filing Details

Accession Number:
0001447362-21-000130
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-10 17:06:42
Reporting Period:
2021-06-08
Accepted Time:
2021-06-10 17:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL Services-Medical Laboratories (8071) 770701774
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1782994 E. Bernhard Spiess C/O Castle Biosciences, Inc.
505 S. Friendswood Drive, Ste. 401
Friendswood TX 77546
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-08 8,989 $1.92 22,551 No 4 M Direct
Common Stock Disposition 2021-06-08 8,989 $70.00 13,562 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2021-06-08 8,989 $0.00 8,989 $1.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,878 2026-05-23 No 4 M Direct
Footnotes
  1. These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 24, 2021.
  2. Includes 1,815 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan.
  3. 25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.